An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-12 | Issue-11
The Role of Radiotherapy in the Management of Wilms Tumor at the Marrakech University Hospital Center: Indications, Dosimetric Parameters, and Clinical Outcomes: A Retrospective Study (2019–2025)
R. Nouhi*, W. Hassar, S. Laatitioui, T. Igarraman, M. Saadoune, N. Oumghar, S. Barkich, M. Darfaoui, A. Elomrani, M. Khouchani
Published: Nov. 21, 2026 | 5 6
Pages: 1240-1248
Downloads
Abstract
Background. Wilms tumor (nephroblastoma) is the most common pediatric renal malignancy. Radiotherapy is a recognized component of multimodal management in defined subgroups, but data describing its practical implementation, dosimetry, and toxicity in resource-limited settings remain scarce. Objectives. To describe the indications, technical parameters, dosimetry, and outcomes of radiotherapy administered to children treated for nephroblastoma at a single tertiary center. Methods. We conducted a retrospective descriptive cohort study of 20 children with histologically confirmed nephroblastoma, all of whom received radiotherapy, managed at the Department of Oncology-Radiotherapy, CHU Mohammed VI, Marrakech, Morocco, between January 2019 and December 2025. Data were extracted from medical records, radiotherapy reports, and imaging archives. Sociodemographic, clinical, diagnostic, therapeutic (chemotherapy, surgery, radiotherapy), and outcome variables were analyzed descriptively (frequencies, percentages, means). Results. The cohort comprised 11 girls and 9 boys (female-to-male ratio not calculated as a formal ratio; 55% vs 45%), with a male-to-female sex ratio of 0.82. Tumors were left-sided in 16 patients (80%). SIOP stage distribution was: stage I, 3 (15%); stage II, 5 (25%); stage III, 8 (40%); stage IV, 4 (20%). Histological risk stratification showed 3 (15%) low-risk, 6 (30%) intermediate-risk, and 11 (55%) high-risk tumors. All patients received neoadjuvant chemotherapy per the GFAOP-Nephro 2005 protocol and underwent radical nephroureterectomy. All 20 patients received conventional three-dimensional conformal radiotherapy (3D-CRT) with curative intent, most commonly to the ipsilateral flank (65%). The mean total dose was 21.6 Gy (range 10.5–25.2 Gy) delivered in 7–14 fractions of 1.5–1.8 Gy, over a mean overall treatment time of 11 days. The mean interval between nephrectomy and radiotherapy initiation was approximately 40,5 days. General toxicity (irradiation-